BAMCO Inc’s Terns Pharmaceuticals TERN Stock Holding History

BAMCO Inc’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-35,000	Closed	-$1.85M	–	369
2026 Q1	$1.85M	Buy	+35,000	New	+$1.44M	0.01%	278

Other funds holding TERN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BAMCO Inc's TERN Position: Q2 2026 in Review

BAMCO Inc sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 35,000 shares — an estimated $1.85M sold.

BAMCO Inc first reported a position in TERN in Q1 2026 and held it in 1 quarter. The position peaked at $1.85M in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

BAMCO Inc reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
BAMCO Inc sold 35,000 Terns Pharmaceuticals shares in Q2 2026, an estimated $1.85M.
BAMCO Inc first reported a position in Terns Pharmaceuticals in Q1 2026 and held it in 1 quarter.
BAMCO Inc's Terns Pharmaceuticals position peaked at $1.85M in Q1 2026.
1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on BAMCO Inc's 13F filing for Q2 2026, filed 14 Aug 2026.